| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/20/2003 | US20030036630 Nucleotide sequences for use in human therapeutics and diagnostics |
| 02/20/2003 | US20030036568 Permeation enhancers |
| 02/20/2003 | US20030036533 Used in infections by viruses, bacteria, fungi, and parasites |
| 02/20/2003 | US20030036526 Activating a signaling cascade comprising, introducing leptin and/or a cytokine to a receptor complex comprising gp 130, to genes in neuro- endocrine cells or cells of neuro-endocrine origin. |
| 02/20/2003 | US20030036525 Hyaluronic acid and/or a salt thereof associated with/bound with an effective amount of anti-sense to the gene implicated in the disease or condition |
| 02/20/2003 | US20030036524 Transfecting with a polynucleotide that comprises a prodrug metabolising gene, and a promoter capable of selectively promoting the transcription of the prodrug metabolising gene in said endothelial cell; and delivering said prodrug |
| 02/20/2003 | US20030036522 Pluripotent cells suitable for transplantation therapy, to repair neural damage, are identified, e.g. by differential display, from a gene expression profile for a selected cell, which can be compared with that obtained from a control cell |
| 02/20/2003 | US20030036521 Also using ADNF III nucleic acid probes to detect the presence of pathologically proliferating cells in human tissues. |
| 02/20/2003 | US20030036519 Stable alteration of pre-mrna splicing patterns by modified rnas |
| 02/20/2003 | US20030036517 Identifying accessible regions in a target RNA molecule using trans-splicing nucleic acid molecules |
| 02/20/2003 | US20030036511 Preparation of pure isoforms using TSK sulfopropyl cation exchange chromatography and reverse phase high performance liquid chromatography. |
| 02/20/2003 | US20030036510 Novel human cell division cycle proteins |
| 02/20/2003 | US20030036507 Urocortin-III and uses thereof |
| 02/20/2003 | US20030036506 Mutated class I major histocompatibility proteins and complexes |
| 02/20/2003 | US20030036503 Method for separating a chemical or biological compound in a mixture of similar compounds by diffusion in a medium such as a gel |
| 02/20/2003 | US20030036198 Novel DNA cloning method |
| 02/20/2003 | US20030036197 Recombinant constructs and their use in reducing gene expression |
| 02/20/2003 | US20030036195 Generation of differentiated tissue from nuclear transfer embryonic stem cells and methods of use |
| 02/20/2003 | US20030036194 Genetically engineered cell for use in regenerative medicine |
| 02/20/2003 | US20030036185 Novel amino acid sequences for human kidney cadherin-like polypeptides |
| 02/20/2003 | US20030036184 Polypeptides exhibiting PDE7 activity and their use for selecting compounds which inhibit PDE 7 enzyme activity |
| 02/20/2003 | US20030036180 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferation disorders |
| 02/20/2003 | US20030036179 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036178 Long wavelength engineered fluorescent proteins |
| 02/20/2003 | US20030036175 Depletion or removal of endotoxins from solution; obtain solution, incubate with chromatographic column, elute, recover endotoxin free solution |
| 02/20/2003 | US20030036174 Hair follicle growth factor proteins |
| 02/20/2003 | US20030036173 Controlling gene expression in living cells |
| 02/20/2003 | US20030036172 Polypeptide for use in the treatment of cancerous, angiogenesis, inflammatory shock and autoimmune diseases |
| 02/20/2003 | US20030036171 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
| 02/20/2003 | US20030036170 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
| 02/20/2003 | US20030036168 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory defects |
| 02/20/2003 | US20030036167 Protease proteins that are related to the choriolytic hatching protease subfamily, recombinant DNA molecules, and protein production. |
| 02/20/2003 | US20030036166 ErbB4 receptor-specific neuregulin related ligands and uses therefor |
| 02/20/2003 | US20030036165 Nucleotide sequences coding polypeptides for use in the treatment of cell proliferation disorders |
| 02/20/2003 | US20030036162 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036161 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036146 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment of cell proliferative disorders |
| 02/20/2003 | US20030036140 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036137 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment of cell proliferative disorders |
| 02/20/2003 | US20030036121 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036118 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | US20030036116 Can be used in combination with other mutagenesis methods |
| 02/20/2003 | US20030036113 Regulatory nucleotide sequences for use as tools in genetic engineering |
| 02/20/2003 | US20030036112 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of nervous system and tumor disorders |
| 02/20/2003 | US20030036111 Transport protein for use in the treatment of mitochondrial, tumor, muscle and viral diseases |
| 02/20/2003 | US20030036110 Isolation of viral envelope proteins; obtain cells transform with vector containing viral protein, propagate cell, lyse cells, recover envelope proteins |
| 02/20/2003 | US20030036108 Detection of cell fusion; obtain cells, measure fluorescence resonance energy transfer, compare to control and evaluate fusion |
| 02/20/2003 | US20030036107 Modulators of leukocyte activation, compositions and methods of use |
| 02/20/2003 | US20030036105 Antigen for use in the diagnosis of nematode infections |
| 02/20/2003 | US20030036096 Chemical-library composition and method |
| 02/20/2003 | US20030036092 Directed evolution of enzymes and antibodies |
| 02/20/2003 | US20030036090 Relaxing solid support for use in biopolymer analysis; obtain relaxable solid support, expose to heat, monitor relaxation of solid support |
| 02/20/2003 | US20030036088 Separation of viruses in sample; obtain sample containing viruses, incubate with filter, recover and analyze preferential virus from filter |
| 02/20/2003 | US20030036081 Distributed system for epigenetic based prediction of complex phenotypes |
| 02/20/2003 | US20030036078 P5CRs as modifiers of the p53 pathway and methods of use |
| 02/20/2003 | US20030036076 CADs as modifiers of the p53 pathway and methods of use |
| 02/20/2003 | US20030036075 Nucleotide sequences coding transport protein for us in the treatment and diagnosis of cancer, arthritis, vision defects and skin dsorders |
| 02/20/2003 | US20030036071 Computational method for inferring elements of gene regulatory network from temporal patterns of gene expression |
| 02/20/2003 | US20030036056 Inhibitors and target molecule co-localization |
| 02/20/2003 | US20030036055 Generation of vector containing preferential insert; obtain nucleotide sequences, incubate with primers, amplify, recover nucleotide sequences |
| 02/20/2003 | US20030036053 Process for typing HCV isolates |
| 02/20/2003 | US20030036051 Methods of screening for antagonists and agonists of polypeptides having kinase functions |
| 02/20/2003 | US20030036050 Recovering enzyme mutant of preferential activity; obtain mutants, display mutants on solid support, monitor structure and activity of mutant |
| 02/20/2003 | US20030036049 Testing drug sensitivity of cells; obtain cells, culture, incubate with test drug, expose to probe, detect signal, determine drug sensitivity |
| 02/20/2003 | US20030035816 Soluble ctla4 mutant molecules and uses thereof |
| 02/20/2003 | US20030035815 Recombitope peptides |
| 02/20/2003 | US20030035814 Cloning Dna; prevention reproduction; gene therapy |
| 02/20/2003 | US20030035807 Self antigen vaccines for treating B cell lymphomas and other cancers |
| 02/20/2003 | US20030035800 Glycosylated humanized B-cell specific antibodies |
| 02/20/2003 | US20030035799 Glycosylated antibody |
| 02/20/2003 | US20030035798 Prevention infections; such as colds, influenza |
| 02/20/2003 | US20030035796 Novel compound for treatment of allergy and asthma |
| 02/20/2003 | US20030035794 Gene-therapeutic nucleic acid construct, production of same and use of same in the treatment of heart disorders |
| 02/20/2003 | US20030035793 Novel immune response targeting molecules |
| 02/20/2003 | US20030035792 Recombinant MVA virus, and the use thereof |
| 02/20/2003 | US20030035789 Purging lymphocytes |
| 02/20/2003 | US20030034993 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/20/2003 | CA2808328A1 Wheat plants having increased resistance to imidazolinone herbicides |
| 02/20/2003 | CA2790951A1 Wheat plants having increased resistance to imidazolinone herbicides |
| 02/20/2003 | CA2763913A1 Antigen binding domains |
| 02/20/2003 | CA2457448A1 Human smooth muscle myosin heavy chain |
| 02/20/2003 | CA2457400A1 Modulation of leukocyte-endothelial interactions following ischemia |
| 02/20/2003 | CA2457349A1 Sub-unit vaccine for infectious pancreatic necrosis virus |
| 02/20/2003 | CA2457059A1 System for detecting protease |
| 02/20/2003 | CA2456979A1 Yield-related polynucleotides and polypeptides in plants |
| 02/20/2003 | CA2456972A1 Stress-related polynucleotides and polypeptides in plants |
| 02/20/2003 | CA2456950A1 Protein design automation for protein libraries |
| 02/20/2003 | CA2456928A1 Cellular virus receptors and methods of use |
| 02/20/2003 | CA2456909A1 Methods for the treatment and prognosis of leukemia and other cancer types |
| 02/20/2003 | CA2456882A1 Modified cyclic nucleotide gated ion channel (cng) comprising methionine or valine substitutions at t537 and uses thereof |
| 02/20/2003 | CA2456857A1 Dna encoding rat bombesin receptor subtype-3 (brs-3) and uses thereof |
| 02/20/2003 | CA2456802A1 Composite superimmunogen for bi-functional vaccine use for the treatment of illnesses associated with a stromal tissue disorder |
| 02/20/2003 | CA2456786A1 Genetic products of ashbya gossypii, associated with transmembrane transport |
| 02/20/2003 | CA2456762A1 Interleukin-1 receptors in the treatment of diseases |
| 02/20/2003 | CA2456719A1 Chimeric proteins comprising a haem domain of a mammalian or plant cytochrome p450 and a scaffold-reductase domain from p450 bm3 of bacillus megaterium and uses thereof |
| 02/20/2003 | CA2456708A1 Crystal forms and mutants of rank ligand |
| 02/20/2003 | CA2456607A1 Uses of mammalian cytokine; related reagents |
| 02/20/2003 | CA2456571A1 Human secreted proteins, their encoding polynucleotides, and uses thereof |
| 02/20/2003 | CA2456565A1 Phenotypic effects of ubiquinone deficiencies and methods of screening thereof |
| 02/20/2003 | CA2456552A1 Compositions and methods relating to the daptomycin biosynthetic gene cluster |